These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9531072)

  • 1. In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
    Baiocchi P; Galiè M; Santini C; Carfagna P; Cassone M; Tarasi D; Venditti M
    J Chemother; 1998 Feb; 10(1):25-8. PubMed ID: 9531072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R; Raad I
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
    Anwar MS; Bokhari SR
    J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
    Voss A; Machka K; Lenz W; Milatovic D
    Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
    Bergeret M; Boutros N; Raymond J
    Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
    Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
    Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Staphylococcus aureus isolated from patients treated at the Clinical Center of Skopje, Macedonia, with special attention to MRSA.
    Cekovska Z; Panovski N; Petrovska M; Kristóf K; Rozgonyi F
    Acta Microbiol Immunol Hung; 2005; 52(3-4):373-84. PubMed ID: 16400877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russia: results of a prospective study.
    Stratchounski LS; Dekhnich AV; Kretchikov VA; Edelstain IA; Narezkina AD; Afinogenov GE; Akhmetova LI; Boronina LG; Gugutcidze EN; Gudkova LV; Zdzitovetcki DE; Ilyina VN; Kretchikova OI; Marusina NE; Multih IG; Pylaeva SI; Smirnov IV; Suborova TN; Taraban VK; Furletova NM; Hasanova SG; Schetinin EV
    J Chemother; 2005 Feb; 17(1):54-60. PubMed ID: 15828444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of oxacillin-resistant Staphylococcus aureus isolates in an Italian University Hospital.
    Venditti M; Baiocchi P; Brandimarte C; Capone A; Fimiani C; Santini C; Tarasi A
    J Chemother; 1994 Feb; 6(1):25-8. PubMed ID: 8071673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
    Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F
    Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter study of Staphylococcus susceptibility to antibiotics in Moscow and St. Petersburg].
    Sidorenko SV; Rezvan SP; Grudinina SA; Krotova LA; Sterkhova GV
    Antibiot Khimioter; 1998; 43(7):15-25. PubMed ID: 9727163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
    Sakoulas G; Gold HS; Venkataraman L; DeGirolami PC; Eliopoulos GM; Qian Q
    J Clin Microbiol; 2001 Nov; 39(11):3946-51. PubMed ID: 11682512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
    Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
    Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections.
    Tallent SM; Bischoff T; Climo M; Ostrowsky B; Wenzel RP; Edmond MB
    J Clin Microbiol; 2002 Jun; 40(6):2249-50. PubMed ID: 12037100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of oxacillin resistance in oxacillin-sensitive Staphylococcus aureus through exposure to ciprofloxacin but not piperacillin/tazobactam.
    Evans ME
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):621-3. PubMed ID: 12226696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.